PATENT CLAIM ANALYSIS

Application Number: 15745431
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-07
Patent Classification: ["514", "04400A"]

Abstract:
Presently disclosed is a method of modulating Hepatitis B virus (HBV) replication, by contacting the cell with at least one agent that modulates at least one factor from a specified group consisting of SNAI2, SOX7 and other factors, the screening of said agent and use thereof in a medicament for treating HBV infection or disease or condition associated with a HBV infection in a subject. In one preferred embodiment, the agent is one peptide derived from SOX7 or SNAI2 or stapled peptides thereof. As a separate invention, a method of identifying at least one factor that modulates replication of a virus is also disclosed.

Claim (Index 43):
The method of  claim 41 , wherein the at least one factor is selected from the group consisting of SNAI2, SOX7, HNF4\u03b11, HNF4\u03b12, HNF4\u03b13, HNF4\u03b17, HNF4\u03b18 and HNF4\u03b19.

Metadata:
- Claim Count in Document: 14.0
- Percentile: 86.0
- Lexical Diversity: 1.80952
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15023284', '15268119', '15309680', '14380583', '13037931']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7662168626320275
- 35 USC 102 Novelty (BERT): 0.5006324463522843
- Combined Prediction Score: 0.7396584210040531
- Mean Citation Score: 205.083358
- Max Citation Score: 234.54459
- Similarity Product: 159.4716316884935

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test